Topic: Service Providers
Practitioners are on the frontline of the drug crisis.
Giving practitioners the support they need is vital. Long experience confirms there are many pathways of recovery: there is no simple, one-shot solution for addiction. Financial, family, community, religious and other factors all add to or detract from recovery capital. Yet funding is too often given to just one or two aspects of the full picture. To make real progress, all phases of recovery must be supported.
Governor DeSantis’ Drug Czar, Doug Simon, comments on Medication-Assisted Treatment
In May 2023, CSDAP staff met with Doug Simon, Governor DeSantis’ Director of the Office of Drug Control (a job often referred to as Drug Czar). He commented on the pros and cons of Medication-Assisted Treatment for those addicted to opioids, alcohol or other drugs and what must be done to reduce the state's problems with drugs and addiction.
Report: The 2023 SAM Summit and Good Drug Policy Conference
On a sparking Washington, D.C. day, 150 attendees and a dozen or so presenters gathered at the Miracle Theater to share news related to drug policy. Presenters included Kevin Sabet emphasizing the need for scientific evidence to lead drug policy decisions, not the popular vote; Dr. Drew Pinsky and his daughter Paulina speaking about the addictive properties of marijuana and the dangers of Delta-8; and Doug Simon, who discussed new pilot programs in Florida to break the cycle of addiction. Other speakers discussed trends in drug abuse and addiction, workplace drug testing fraud and much more.
MAT: Overdose Prevention or Treatment Leading to Real Recovery?
Medication-assisted treatment is America's primary offering for those who are addicted. But implicit in the word “treatment” is recovery from an illness or other condition—as in "not suffering from that condition any longer." Is medication-assisted treatment really a recovery-oriented therapy? Or is its primary role preventing a person from relapse and overdose? These are questions those involved in addiction recovery should be asking.
Will the White House’s “X waiver” elimination have unintended consequences?
According to an article in Politico, the White House held a ceremony on January 24, 2023 to sign the Mainstreaming Addiction Treatment (MAT) Act. This Act eliminated the special training requirement for doctors and other health practitioners who wanted to prescribe medication-assisted treatment to the opioid-addicted. While making medication-assisted treatment more broadly available could be a positive move, does it take into account the care that the opioid-addicted really need ?
Can the scope of addiction treatment be changed with a single word?
Government agencies like the Substance Abuse and Mental Health Services Administration, the Department of Health and Human Services (HHS) and the National Institute on Drug Abuse (NIDA) are continuously involved in setting the standards for treatment of addiction. They publish guidelines for both drug rehab facilities and those seeking rehab. Therefore, the exact wording of their guidelines is of utmost importance. A subtle shift could result in unintended and undesirable changes in treatment.
Study finds marijuana with high THC levels linked to addiction, psychiatric illness
As the strength or potency of cannabis products has increased internationally over the years, so have rates of people being treated for cannabis addiction, say the authors of a new study. Researchers from the Addiction and Mental Health Group at the University of Bath (UK) systematically analysed the relationship between the types of cannabis people use and their addiction and mental health problems. Their work draws on 20 studies involving almost 120,000 people.
Should people with addiction disorders be forced by governments into treatment?
Governor Gavin Newsom of California has proposed a court program that would force unhoused people with severe mental illnesses and addiction disorders into treatment. The moves comes in response to a worsening humanitarian crisis concerning people living on the streets, but has raised concerns from disability rights and civil liberties advocates. According to the proposed plan, those who do not follow through with the treatment could be forced into conservatorships.
Indivior must face states’ monopoly claim over opioid addiction drug Suboxone
(Reuters) - Drugmaker Indivior Inc must face a lawsuit by 42 state attorneys general accusing it of using illegal tactics to shield its opioid addiction treatment Suboxone from generic competition, a federal judge has ruled. States have said that the company's conduct forced consumers to pay inflated prices for the treatment amid an epidemic of opioid addiction. U.S. District Judge Mitchell Goldberg in Philadelphia found Monday that a reasonable jury could find that Indivior's switch from a pill to an oral film form of the drug in 2009 was intended to extend its monopoly just as generic manufacturers were poised to begin selling their own pills, a strategy known as product hopping.